
Angie Drakulich
Executive Editor and Content Director at Practical Pain Management
Executive Managing Editor at MedCentral
A. Drakulich is the Editorial Director of Pharmaceutical Technology and BioPharm International.
Articles
-
3 weeks ago |
medcentral.com | Susan Redline |Angie Drakulich |Avery Hurt |Patrice Wendling
Intensive medical treatment did not reduce the risk of major adverse cardiovascular events (MACE) at 5 years compared with usual care among women with ischemia and nonobstructive coronary artery disease in the WARRIOR trial. Results were presented at the American College of Cardiology (ACC25) annual meeting and are under review by JAMA.
-
3 weeks ago |
medcentral.com | Angie Drakulich |Heidi Splete |Avery Hurt |Patrice Wendling
Once-daily, add-on treatment with the aldosterone synthase inhibitor lorundrostat significantly reduced blood pressure in adults with uncontrolled and treatment-resistant hypertension in a second pivotal trial, ADVANCE-HTN. Results were presented at the American College of Cardiology annual scientific session (ACC.25) this past weekend and are accepted for publication in the New England Journal of Medicine.
-
1 month ago |
oncologynewscentral.com | Diana Swift |Aaron Tallent |Marcia Frellick |Angie Drakulich
This past January, Bryan Hambley, MD, MPH, a hematologist-oncologist at the University of Cincinnati Health, announced that he is running to be Ohio’s next secretary of state. He says that he is driven by the desire to create summaries of ballot proposals that are honest and clear to voters, something that he says current Secretary Frank LaRose, who holds the office until 2027, fails to do.
-
2 months ago |
medcentral.com | Emily Bader |Angie Drakulich |Ryan Syrek
Physicians are feeling the effects of federal healthcare policies in their clinical practice, survey results show. From presidential executive orders to fluctuating Medicaid access, these shifts are rapidly reshaping the medical landscape in real time. MedCentral – in partnership with Oncology New Central and TheBodyPro – asked doctors how these actions, many stemming from the new Trump administration, are affecting patient care. Here’s what they had to say.
-
2 months ago |
medcentral.com | David Provenzano |Angie Drakulich
The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) published guidelines last month on surgical site infections that occur from pain management procedures, such as injections, nerve blocks, and intrathecal or spinal cord stimulator implants.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 110
- Tweets
- 112
- DMs Open
- No

Are you up to date on laboratory qualification and compliance? Watch a free PharmTech webcast on this topic. http://t.co/ktoDnuuh

Are you update to date on analytical testing trends and requirements? An entire PharmTech issue covers this topic http://t.co/KUoBkvq9

going to the PDA FDA Vaccines conference in December? Listen to our podcast about what to expect. http://t.co/crIFQMbB